FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/02/2025
Voltar para busca
Dado oficial do USPTO
NUAGE THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NUAGE THERAPEUTICS
ST13
US500000079370637Classe
1, 5, 40, 42
Pedido
79370637
Registro
7459228
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42
Data de depósito
25/11/2022
Data de registro
30/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/07/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
ES
Examinador
BHANOT, KAPIL KUMAR
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Nuage Therapeutics, S.L.
Representantes
Lawrence Apolzon Fross Zelnick Lehrman & Zissu, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in product development in the fields of sciencescientific research and for laboratory use; in vitro analytical and diagnostic reagents for scientific use
Classe 5
Pharmaceutical preparations for targeting of disordered proteins; chemicalanalytical and diagnostic reagents for in vitro medical or veterinary use; chemical reagents for medical use; chemical reagents for use in medical or veterinary diagnostics; pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions and for the treatment of inflammation and inflammatory conditions and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the prevention and treatment of immune-relatedneurological and neurodegenerative diseases
Classe 40
Custom manufacture of cell lines for use in the manufacture of biopharmaceutical products; custom manufacture of proteins for third parties; custom manufacture of medicines; custom manufacture of biopharmaceuticals
Classe 42
Scientificmedicalmedical industrial research and development services; medical clinical research studies; laboratory medical research; research and development of new drugs and medical clinical products; analysis of materials; chemical analysis; medical and scientific laboratory services; laboratory medical testing services; medical laboratory services; information and advisory services relating to the aforesaidincluding such services provided online from a computer network or via the internet; research and development services for pharmaceutical preparations and for the treatment of diseases and injuries; genetic engineering services; genetic research for scientific or medical purposes; scientific research and development; scientific research in the field of genetics; medical and pharmacological research services; research and development in the fields of biotechnologybiopharmaceuticalsgene therapies; medical and scientific researchnamely conducting clinical trials; research and development of pharmaceutical products; research and development of vaccines and medicines; stem cell research; research and development in the fields of microorganisms and cells; research in the field of gene therapies; advisory services relating to gene therapy research; biological researchclinical medical research and medical research; product development; biological product development services; consultancy relating to pharmaceutical research and development; providing scientific information in the field of medical disorders and their treatment; pharmaceutical research and development; scientific services relating to the isolation and cultivation of human tissues and cells; research related to molecular science; analysis in the field of molecular biology; research services relating to molecular sciences
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/01/2025
FIMP
FINAL DISPOSITION PROCESSED
28/01/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/07/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
30/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/05/2024
PUBO
PUBLISHED FOR OPPOSITION
14/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/03/2024
RFNT
REFUSAL PROCESSED BY IB
17/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/09/2023
RFRR
REFUSAL PROCESSED BY MPU
27/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/09/2023
CNRT
NON-FINAL ACTION WRITTEN
08/09/2023
DOCK
ASSIGNED TO EXAMINER
06/09/2023
MAFR
APPLICATION FILING RECEIPT MAILED
30/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/05/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/05/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NUAGE THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.